Date:3/10/2009

stituto de Biologia Experimental e Tecnologica (IBET) is a private not for profit institution created in 1989 to integrate and strengthen biological and biochemical knowledge from its academic and industrial partners into technology and transfer it into economic wealth and job creation. Science and technology are used together to ensure the translational application of competences from early stage discovery to final production and processes. IBET has 20 years of experience in biopharmaceuticals development and over 10 years experience in cell line creation and cryobiology. In its Animal Cell Technology Laboratory, work has been ongoing with recombinant and fusion proteins for diagnostics and therapeutics, subunit and virus like particle (VLP) vaccines, vectors for gene therapy (retro-, lenti-, adeno- and, more recently, baculovirus) and stem cells for cell therapies (neuronal, hepatocytes). For more information please visit http://www.ibet.pt.

About Fraunhofer Institute for Biomedical Engineering:

The Fraunhofer Institute for Biomedical Engineering IBMT is your partner in offering solutions for individual tasks in the areas of Biomedical-/medical engineering, sensor- and measuring technologies, ultrasound technologies, health telematics, biotechnology and biohybrid technology, cryo(bio)technology and nano(bio)technology, environmental control systems, material testing, home systems, air quality control and security systems as well as industrial process automation and in-line/on-line process control.

For more information please visit http://www.ibmt.fraunhofer.de/fhg/ibmt/index.jsp.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include
'/>"/>

SOURCE BioLife Solutions, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Waters Corporation Continues to Meet Todays Challenges for Improved Laboratory Operations with New Products at Pittcon 2009
2. New Study Reports Improved Patient Outcomes for Breast Cancer Patients
3. Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon
4. Research highlights potential for improved solar cells
5. A need for improved efficiency in nanomanufacturing
6. One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
7. In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care
8. Finesse Solutions Launches Improved E-Store for Sensors and Transmitters
9. Kelly Osbourne and International Health Groups Call for Improved Education on Choices and Usage of Contraception
10. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
11. Improved culture system for hepatitis C virus infection